Amelia A Langston MD

Hematologic Oncology

Professor, Hematology and Medical Oncology, Emory University School of Medicine

1365 Clifton Rd NeAtlanta, GA 30322
Phone+1 404-778-1900

Dr. Langston is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Langston's full profile Already have an account?

Education & Training

University of WashingtonFellowship, Medical Oncology, 1987 - 1989
Duke University HospitalResidency, Internal Medicine, 1984 - 1987
WashU MedicineClass of 1984

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

GA State Medical License 1998 - 2027
NC State Medical License 1984 - 1999
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2013, 2015-2017
CMS Meaningful Use Stage 2 Certification FirstNet (CQM), Cerner Corporation, 2013, 2015-2017
CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2013, 2015-2017

Clinical Trials

Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies Start of enrollment: 1998 Jul 01
Completed
Phase 2
Allogeneic Cell Therapy for Adults With Hematologic Malignancies Start of enrollment: 1998 Sep 01
Completed
Phase 2
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
COMPLETED
PHASE3

Publications & Presentations

PubMed

Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.
Saubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, Susan M Geyer, Ali Alsugair
American Journal of Hematology. 2026-09-01
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.
Takuto Takahashi, Benjamin Watkins, Brandi Bratrude, Donna Neuberg, Kyle Hebert
Transplantation and Cellular Therapy. 2025-02-01
Hodgkin Lymphoma Treatment With Brentuximab Vedotin in a Patient With HIV, Liver Failure, and Anemia Without Transfusion.
Ellen Marin, Aseala Abousaud, Kathleen Davis, Bradley Sumrall, Shiyong Li
Ejhaem. 2025-02-01

Abstracts/Posters

Outcomes of Elderly Patients Undergoing Allogeneic Transplantation for Acute Myeloid Leukemia with Fludarabine/Melphalan or Fludarabine/TBI Conditioning Regimen
Amelia Langston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Transcriptomic Analysis of CD4+ T Cell Dysfunction during Gvhd: Evidence for Profound Reprograming of T Cell Signaling during Acute Gvhd That Is Controlled during CD28...
Amelia Langston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Winship Research Contributes to FDA Approval of First-Ever Drug for Acute GVHDDecember 19th, 2021
Our Stories Ep. 19 (Dr. Amelia Langston)January 15th, 2021
Childhood Leukemia May Be Triggered by Germs, Could Be Prevented, Study SuggestsMay 25th, 2018